Evofem Biosciences, Inc. (EVFM)
OTCMKTS
· Delayed Price · Currency is USD
0.0090
-0.0002 (-2.17%)
Apr 2, 2025, 4:00 PM EST
Evofem Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | - | - | 2.77 | 7.73 | 48.89 | Upgrade
|
| Short-Term Investments | 0.13 | 0.08 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 0.13 | 0.08 | 2.77 | 7.73 | 48.89 | Upgrade
|
| Cash Growth | 67.11% | -97.25% | -64.19% | -84.19% | 105.39% | Upgrade
|
| Accounts Receivable | 9.83 | 5.74 | 1.13 | 6.45 | 1.07 | Upgrade
|
| Receivables | 9.83 | 5.74 | 1.13 | 6.45 | 1.32 | Upgrade
|
| Inventory | 1.58 | 1.7 | 5.38 | 7.67 | 7.16 | Upgrade
|
| Prepaid Expenses | 0.39 | 0.78 | 1.39 | 2.6 | 16.7 | Upgrade
|
| Restricted Cash | 0.74 | 0.58 | 1.21 | 5.06 | 22.56 | Upgrade
|
| Other Current Assets | 0.94 | 0.34 | 0.83 | 0.63 | 1.1 | Upgrade
|
| Total Current Assets | 13.61 | 9.21 | 12.7 | 30.14 | 97.73 | Upgrade
|
| Property, Plant & Equipment | 0.55 | 1.31 | 8.35 | 11.17 | 11.19 | Upgrade
|
| Other Intangible Assets | 9.6 | - | - | - | - | Upgrade
|
| Other Long-Term Assets | 0.04 | 0.04 | 4.12 | 1.2 | 1.05 | Upgrade
|
| Total Assets | 23.79 | 10.55 | 25.16 | 42.51 | 109.97 | Upgrade
|
| Accounts Payable | 16.17 | 17.02 | 14.98 | 10.32 | 10.64 | Upgrade
|
| Accrued Expenses | 9 | 6.84 | 6.3 | 13.72 | 10.99 | Upgrade
|
| Short-Term Debt | 15.11 | 14.73 | 39.42 | 81.72 | 52.41 | Upgrade
|
| Current Portion of Long-Term Debt | 30.77 | 28.54 | 26.27 | 27.21 | - | Upgrade
|
| Current Portion of Leases | 0.08 | 0.1 | 2.31 | 2.33 | 2.29 | Upgrade
|
| Other Current Liabilities | 9.31 | 5.24 | 4.55 | 2.37 | 0.95 | Upgrade
|
| Total Current Liabilities | 80.45 | 72.46 | 93.83 | 137.66 | 77.28 | Upgrade
|
| Long-Term Debt | - | - | - | - | 25.21 | Upgrade
|
| Long-Term Leases | 0.01 | 0.01 | 3.13 | 4.42 | 6.03 | Upgrade
|
| Other Long-Term Liabilities | 9.81 | - | - | - | 0.1 | Upgrade
|
| Total Liabilities | 90.26 | 72.47 | 96.96 | 142.09 | 108.62 | Upgrade
|
| Common Stock | 0.01 | 0 | - | 0.02 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 829.03 | 823.04 | 817.37 | 751.26 | 656.83 | Upgrade
|
| Retained Earnings | -897.66 | -888.7 | -938.69 | -860.68 | -655.49 | Upgrade
|
| Comprehensive Income & Other | -2.63 | -0.85 | 49.53 | 5.09 | - | Upgrade
|
| Total Common Equity | -71.26 | -66.51 | -71.8 | -104.32 | 1.35 | Upgrade
|
| Shareholders' Equity | -66.48 | -61.92 | -71.8 | -99.58 | 1.35 | Upgrade
|
| Total Liabilities & Equity | 23.79 | 10.55 | 25.16 | 42.51 | 109.97 | Upgrade
|
| Total Debt | 45.97 | 43.37 | 71.13 | 115.68 | 85.94 | Upgrade
|
| Net Cash (Debt) | -45.84 | -43.3 | -68.36 | -107.95 | -37.05 | Upgrade
|
| Net Cash Per Share | -0.61 | -0.04 | -146.70 | -1546.16 | -1034.37 | Upgrade
|
| Filing Date Shares Outstanding | 113.36 | 45.94 | 1.73 | 0.09 | 0.04 | Upgrade
|
| Total Common Shares Outstanding | 113.36 | 20.01 | 0.98 | 0.09 | 0.04 | Upgrade
|
| Working Capital | -66.84 | -63.25 | -81.13 | -107.52 | 20.45 | Upgrade
|
| Book Value Per Share | -0.63 | -3.32 | -72.91 | -1203.63 | 31.05 | Upgrade
|
| Tangible Book Value | -80.85 | -66.51 | -71.8 | -104.32 | 1.35 | Upgrade
|
| Tangible Book Value Per Share | -0.71 | -3.32 | -72.91 | -1203.63 | 31.05 | Upgrade
|
| Machinery | 0.73 | 1.23 | 2.17 | 2.15 | 1.7 | Upgrade
|
| Construction In Progress | 0.43 | 1.16 | 1.57 | 2.41 | 2.25 | Upgrade
|
| Leasehold Improvements | - | - | 3.39 | 3.39 | 1.54 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.